NCT00059787 2015-12-01Erlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaNational Cancer Institute (NCI)Phase 2 Completed56 enrolled 10 charts
NCT00126542 2014-05-14Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerNational Cancer Institute (NCI)Phase 2 Completed35 enrolled